Eli Lilly & Co. (LLY) – Insiders' Blog
-
Pharma Stocks Drop After Trump Tweets Drug Prices Will 'Come Way Down!' (IBB)
-
Complete Donald Trump Stock Impact Guide
-
FBN's Maria Bartiromo to Anchor Live from 33rd Annual J.P. Morgan Healthcare Conference
-
FDA to Review Certain Diabetes Drugs Over New Pancreas Concern (BMY) (LLY) (MRK)
-
Pfizer's Zoetis (ZTS) May be Largest IPO Since Facebook (FB)
-
Alkermes (ALKS), Amylin (AMLN) Halted, Could Be Related to Bydureon Decision by FDA
-
Merck (MRK) Has Attractive Dividend, Growth Potential - Barron's
-
Apple (AAPL), Halliburton (HAL), Google (GOOG) Among Most Popular Stocks for 2011
-
Novo Nordisk (NVO) Still Poised to Gain Despite Strong 2010 - Barron's
-
Meet Your New Dividend Aristocrats (MKC, HRL, ECL)
-
Soros' Moves Lower in Telecom, Major Retailers; Becomes Bullish on the U.S. Dollar (T, S, UUP, WMT, SIRI, More...)
-
Wall Street Hubbub 7/21: Traders Nervous Ahead NFLX/BIDU Results, Dimon & Blankfein Not Welcome at FinReg Signing, Bernanke Set to Testify, BIIB/LLL/DTG In the Rumor Mill
-
Wall Street Hubbub 7/14: iPhone 4 Recall, Penthouse-for-Playboy, BP's New Cap Is No Savior, KKR IPO, Treasury Weighs Citi (C) Options
-
Dendreon (DNDN) 17% 4-Day Jump Raises Eyebrows; Is a Deal in the Works?
-
Roche's Taspoglutide Setback Gives Amylin (AMLN) A Boost
-
Traders Mostly Shrugging-Off Eli Lilly's (LLY) Mixed Q1 Results
-
Icahn Gets Another Seat on Biogen (BIIB) Board
-
Drug Makers Higher On Health Care Reform (PFE, MRK, TEVA, more...)
-
Health Care Investors Get What They Wanted: A Brown Win In Massachusetts
-
Health Care Stocks Jump On Expectations for Republican Upset In Massachusetts (HUM, UNH, PFE, more...)
-
While Attention Is on a Pfizer (PFE) Dividend Raise, Merck (MRK) Could Be Ripe for a Hike Too - Analyst
-
Eli Lilly (LLY) Shines In Third Quarter
-
Eli Lilly (LLY) Down on Convction Sell, Merck (MRK) Up On Conviction Buy
-
Does CV Therapeutics (CVTX) Have A Case of Merger-Cockiness?
-
Top 15 For 2008 (No. 14): M&A Wreckage
-
Cramer Says Eli Lilly (LLY) Stock Has Already Bottomed
-
Amylin Pharma (AMLN) Higher After Icahn Boosts Stake
-
Analyst Expects Immediate $70/Share Offer for ImClone (IMCL) from Bristol-Myers Following News
-
Amylin (AMLN) Gets A Friend After Yesterday's 25% Sell-Off
-
Wall Street Throws In the Towel On Amylin (AMLN) Following New Byetta Patient Deaths
-
Gates' The Bill and Melinda Gates Foundation Shows New Positions in Crocs (CROX), Dick's (DKS) and Raised Stakes in McDonald's (MCD), FedEx (FDX) and AIG (AIG)
-
Major Drug Companies Fall to New 52-Week Lows (PFE, GSK, MRK, LLY, BMY)
Back to LLY Stock Lookup